The Edge of Epidemiology

Disease intelligence sheet

Pertussis

Curated desk background for reporters who need the pathogen, transmission, and outbreak frame fast.

Vaccine-preventableRespiratoryRecurring resurgenceSchoolsHouseholdsCommunities with waning immunity or low uptake

Pathogen / agent: Bordetella pertussis

Transmission: Respiratory droplets

Reservoir / vector: Humans are the reservoir.

Incubation: Usually 5 to 10 days, though it can be longer.

Severity: Often prolonged and disruptive, with severe risk concentrated in infants.

Diagnostics: PCR, culture, and careful clinical timing.

Treatment: Macrolides and supportive care, with prophylaxis for defined contacts.

Prevention: Vaccination, booster policy, and protecting infants through maternal immunization and rapid case recognition.

Vaccine / prevention status: Vaccination exists, but waning immunity, booster policy, and infant protection remain live public-health issues.

Symptoms And Clinical Pattern

  • Catarrhal illness early, followed by paroxysmal cough.
  • Classic whoop is not universal, especially in adults.
  • Infants face the greatest severe-disease risk.

Official Background Links

Current Story Files

No active tracked stories are linked to this disease in the current run.

Why Reporters Care

Why this keeps becoming news: Pertussis repeatedly becomes news because it combines school spread, infant risk, vaccine debates, and underrecognized adult transmission.

What journalists often get wrong: Coverage often assumes a classic whooping presentation, when many adolescent and adult cases are clinically subtler but epidemiologically important.

Last Major Outbreak On File

Post-pandemic resurgence pattern | Multi-country | 2024-2026

Recent pertussis reporting has reflected broader post-pandemic resurgence patterns, with public-health attention on school clusters, infant protection, and under-recognition in older age groups.

Source: CDC overview (CDC overview)

Desk Notes And Historical Signals

Desk note: Worth keeping on the desk because infant risk, school spread, and booster debates all make it newsy.

Research caveats: Reported burden depends heavily on testing intensity and clinical suspicion, so many systems still undercount adult disease.